Aflatoxin B2

Aflatoxins are among the small handful of food contaminants with a proven link to liver cancer in people. This test looks for one member of that toxin family in your urine, giving you a snapshot of whether contaminated food has passed through your body in roughly the last day or two.

It will not tell you your lifetime exposure, and in most people living in well-regulated food systems it reads as undetectable. A positive result is a concrete signal that something you recently ate carried a mold toxin worth tracing.

What This Test Measures

AFB2 (aflatoxin B2) is one of four naturally occurring aflatoxins, poisons produced by the molds Aspergillus flavus and Aspergillus parasiticus when they grow on stored crops. A. flavus typically makes only the B-type toxins (B1 and B2), while A. parasiticus makes all four, and contaminated food often carries a mixture from both. This test measures the parent toxin itself in urine, which reflects recent dietary intake rather than any process your own body creates.

AFB2 is the least studied of the common urinary aflatoxin signals. Most human biomonitoring instead tracks a related molecule called AFM1 (aflatoxin M1), the main breakdown product your liver makes from the more dangerous aflatoxin B1. When researchers do look for AFB2 in urine, they usually find it in a minority of people or not at all.

In a Portuguese study of 94 adults, AFB2 turned up in 16% of urine samples. In a Spanish group of 540 women, aflatoxins overall were measurable in only 3% of samples. In separate studies from Germany and Brazil, AFB2 was not detected in a single urine sample even with highly sensitive equipment. This is a low-yield marker: absence of a signal is the common result, not proof that you have never been exposed.

Recent Exposure, Not Lifetime Burden

Urinary aflatoxin signals clear quickly. Research on related aflatoxin markers such as AFM1 shows that urine reflects intake over roughly the previous 24 to 48 hours, while the short-lived DNA-bound form reflects a similar one-to-two-day window rather than any longer history. If you ate contaminated food last week but nothing since, your urine may read clean today.

Longer-term exposure is captured by a different measurement entirely: aflatoxin bound to a blood protein called albumin, which integrates intake over about two to three months. That blood-based marker measures a related aflatoxin, not AFB2, so a urine test and a blood adduct test answer different questions. Urine tells you about the last day or so; the blood adduct tells you about the last season.

The Liver Cancer Connection

The strongest reason to care about any aflatoxin exposure is liver cancer, specifically hepatocellular carcinoma (the most common form of primary liver cancer). A large study following men in Shanghai found that those who developed liver cancer were about 2.4 times as likely to have detectable urinary aflatoxin markers as those who stayed cancer-free. After accounting for hepatitis B, smoking, alcohol, and education, the risk rose to about 3.8 times, and one specific urinary marker carried roughly a sixfold risk.

Those studies measured other urinary aflatoxin markers (aflatoxin B1, AFM1, aflatoxin P1, and the DNA-bound form), not AFB2 specifically. AFB2 belongs to the same toxin family and generally appears in urine only when a person is also exposed to these more studied and more dangerous relatives, so a positive AFB2 result flags membership in the exposed group rather than a separately quantified cancer risk.

The danger multiplies with chronic viral hepatitis. Aflatoxin and hepatitis B infection interact in the liver so that their combined risk is far greater than either alone. In tumors from high-exposure regions, aflatoxin leaves a distinctive fingerprint mutation in a tumor-suppressor gene called TP53, accounting for roughly half of the mutations in those cancers, compared with under 6% in low-exposure populations.

Why a Small Toxin Still Deserves Attention

It can seem contradictory that AFB2 is called both a concern and comparatively harmless. The resolution is chemistry. AFB2 lacks a reactive chemical feature (a double bond) that makes aflatoxin B1 so damaging, and on its own it is relatively low in toxicity unless the body converts it toward the more reactive form. This is not a good-number or bad-number marker; it is an exposure flag. A detectable AFB2 result matters less for its own toxicity and more because it signals that aflatoxin-contaminated food reached you, which usually means co-exposure to the far more carcinogenic aflatoxin B1.

Child Growth and Other Effects

Beyond cancer, chronic aflatoxin exposure has been linked in human studies to impaired growth in children, weakened immune function, and liver injury, though this evidence is weaker and less consistent than the liver cancer data. In one cohort of acutely ill children, the highest exposure group among non-wasted children had about 4.8 times the odds of dying, but severe malnutrition was a stronger driver of death overall. These findings come from blood-based aflatoxin measurements tied to aflatoxin B1, not urinary AFB2.

Why a Single Reading Can Fool You

Several factors make one AFB2 reading an unreliable stand-in for your true exposure:

• Low detection frequency: AFB2 is often undetectable even in genuinely exposed people, so a negative result does not rule out that you eat contaminated food. The more sensitive urinary marker AFM1 is positive far more often in the same populations.
• Recent diet drives the number: the signal reflects only the last day or two of eating. A clean result after a week of careful eating tells you little about your usual exposure.
• Urine dilution: how much water you drank changes the raw concentration. Good labs correct for this by adjusting to creatinine, a waste product that tracks how concentrated your urine is; without that correction, a diluted sample can read falsely low.
• Assay differences: parent aflatoxins like AFB2 are captured by targeted lab methods that a routine urinalysis does not include, and workflows differ between labs in what they can detect.

Tracking Your Trend

Because this marker captures such a narrow window, a single measurement is close to meaningless on its own. The value comes from repeated sampling that shows whether exposure is a recurring pattern or a one-off. Aflatoxin levels vary by season, region, and even from meal to meal, so several readings spread across time paint a truer picture than any one result.

A practical approach is a baseline, a repeat within a few weeks if you suspect an ongoing dietary source, and periodic checks after you change what you eat. One caution on using retests to confirm a food change worked: the clearest evidence that switching to safer food lowers urinary aflatoxin comes from studies measuring AFM1, not AFB2 directly. Given how often AFB2 reads undetectable, pairing it with AFM1 gives you a more responsive marker to trend.

What an Unexpected Result Should Prompt

A detectable AFB2 result is a starting point for investigation, not a diagnosis. The most useful next step is to widen the picture rather than repeat the single test in isolation. Consider a broader urinary mycotoxin panel, since aflatoxins rarely travel alone and co-exposure to other mold toxins is common. Adding the more sensitive AFM1 marker helps confirm whether the finding reflects a real, ongoing exposure.

If exposure looks repeated or high, the workup shifts toward the liver. Liver enzymes, a liver cancer screening protein, and your hepatitis B and C status together determine how much a given exposure actually matters for you, because viral hepatitis dramatically amplifies aflatoxin risk. A combination of confirmed recurring exposure plus chronic hepatitis is the pattern that warrants involving a hepatologist or toxicology specialist and tracing the food source, whereas an isolated low-level signal in an otherwise healthy person with normal liver markers is a prompt to review your diet and retest, not to alarm.